ndas in ovarian cancer and hcc, and highlights from 2016 kcs and lugpa annual meeting
Published 7 years ago • 94 plays • Length 6:21Download video MP4
Download video MP3
Similar videos
-
0:31
preview: ndas in ovarian cancer and hcc, and highlights from 2016 kcs and lugpa annual meeting
-
1:23
bladder cancer research at esmo 2021
-
5:39
ductal carcinoma in situ: anastrozole versus tamoxifen
-
0:40
nadofaragene firadenovec shows durable responses in nmibc
-
1:06
dr. boisen on neoadjuvant chemotherapy versus upfront surgery in ovarian cancer
-
1:12
scott tagawa, md, on the study investigating nadofaragene firadenovec in bcg unresponsive nmibc
-
2:08
ask our expert about gynaecological cancer
-
0:49
current challenges in the ovarian cancer field
-
1:07
immunotherapy in gynecological cancers
-
1:07:48
2023 asn tma forum: cancer induced tma
-
1:23
dr. duska on neoadjuvant chemo vs upfront surgery in ovarian cancer
-
18:31
oca symposium: dale garsed on immunotherapy
-
1:00:50
screening in familial non-medullary thyroid cancer with dr. klubo gwiezdzinska
-
1:25
bladder cancer research: immunotherapy outcomes | dana-farber cancer institute
-
4:43
genetics and prostate cancer (#7)
-
2:01:38
cancer & i - specially for the gentlemen
-
1:41
safety & efficacy of nadofaragene firadenovec for patients with high-grade, bcg unresponsive nmibc
-
1:21
genomic differences between urachal and non-urachal bladder adenocarcinoma
-
2:20
genitourinary neoplasms